Sinonasal Carcinoma — Trials

Sinonasal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

57 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07645846	Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma(PANDA)	not yet recruiting	Phase 2	23	Sun Yat-sen UniversityOTHER	0	Jun 25, 2026	clinicaltrials
NCT05151588	Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma	not yet recruiting	Phase 2	30	Dr. Victor H.F. LeeOTHER	0	Feb 28, 2023	clinicaltrials